Search Results 431-440 of 17963 for In+vivo

  1. Targeting of Hepatic Stellate Cell PD-L1 To Inhibit Tumor Microenvironment and Cholangiocarcinoma - Mayo Clinic Research

    This work in the Developmental Research Program in the Mayo Clinic Hepatobiliary SPORE studies the tumor microenvironment and the development of ...

  2. Neurology - Clinical trials - Mayo Clinic

    In Vivo Development of Phosphorus Magnetic Resonance Imaging Technology. Rochester, Minn. The goal of this study is to evaluate and optimize our existing ...

  3. Meningeal Lymphatics and Neurological Disorders: Sandro Da Mesquita

    The Meningeal Lymphatics and Neurological Disorders Lab led by Sandro Da Mesquita, Ph.D., studies the meningeal lymphatic system's role in neurological ...

  4. Neurology - Clinical trials - Mayo Clinic

    In addition to Tier 1 procedures, at each in-person follow-up visit: Tier 2 participants will also undergo MRI scanning, comprehensive cognitive assessment ...

  5. Tomorrow's Cure: Inside EVLP - a revolution for donor organs - Mayo Clinic News Network

    This episode of "Tomorrow's Cure" explores how ex vivo lung perfusion (EVLP) breaks new ground as a procedure that evaluates lungs outside the body. This ...

  6. A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors - Mayo Clinic

    This is a multicenter, open-label, first-in-human Phase 1 study evaluating the anti programmed death receptor 1 (anti-PD-1) antibody TSR-042 in patients with ...

  7. Neurology - Clinical trials - Mayo Clinic

    In Vivo Development of Phosphorus Magnetic Resonance Imaging Technology. Rochester, Minn. The goal of this study is to evaluate and optimize our existing ...

  8. Gene Editing and Cellular Engineering: David (Chun-Wei) D. Chen - Mayo Clinic Research

    ... in vivo mouse modeling. Our findings reveal that COX4I1 regulates mitochondrial homeostasis, cristae architecture, oxidative phosphorylation and sensitivity ...

  9. Vedolizumab In The Prophylaxis Of Intestinal Acute Graft Versus Host Disease (AGVHD) In Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation - Mayo Clinic

    Vedolizumab In The Prophylaxis Of Intestinal Acute Graft Versus Host Disease (AGVHD) In Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) ...

  10. Publications - Ming Yang, M.D. - Mayo Clinic

    Evaluation of Hepatotoxicity from Peptide Receptor Radionuclide Therapy in Patients with Gastroenteropancreatic Neuroendocrine Tumors and a Very High Liver ...